Document is current

Any future updates will be listed below

Orales Azacitidin zur Erhaltungstherapie bei Patienten mit AML

Crossref DOI link: https://doi.org/10.1007/s15004-021-8552-7

Published Online: 2021-03-22

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark